Adlai Nortye Ltd. American Depositary Shares (ANL) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 9.00
(+426.32%)
Based on the Adlai Nortye Ltd. American Depositary Shares stock forecast from 1 analysts, the average analyst target price for Adlai Nortye Ltd. American Depositary Shares is USD 9.00 over the next 12 months. Adlai Nortye Ltd. American Depositary Shares’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Adlai Nortye Ltd. American Depositary Shares is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Adlai Nortye Ltd. American Depositary Shares’s stock price was USD 1.71. Adlai Nortye Ltd. American Depositary Shares’s stock price has changed by -11.86% over the past week, -22.27% over the past month and -86.21% over the last year.
No recent analyst target price found for Adlai Nortye Ltd. American Depositary Shares
No recent average analyst rating found for Adlai Nortye Ltd. American Depositary Shares
Company Overview Adlai Nortye Ltd. American Depositary Shares
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent non-small cell lung cancer and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer, microsatellite stable colorectal cancer, and cervical cancer after standard of care treatments; and AN4005, an oral small-molecule PD-L1 inhibitor, which is in Phase I clinical trial to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and antigen-presenting cell modulator; AN1025, an oral small molecule degrader of ß-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was founded in 2004 and is based in Grand Cayman, the Cayman Islands. Read Less
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the tre...Read More
Frequently Asked Questions About Adlai Nortye Ltd. American Depositary Shares (ANL) Stock
Based on ratings from 1 analysts Adlai Nortye Ltd. American Depositary Shares's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on ANL's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for ANL is USD 9.00 over the next 12 months. The maximum analyst target price is USD 9 while the minimum anlayst target price is USD 9.
Unfortunately we do not have enough data on ANL's stock to indicate if its overvalued.
The last closing price of ANL's stock was USD 1.71.
The most recent market capitalization for ANL is USD 0.11B.
Based on targets from 1 analysts, the average taret price for ANL is projected at USD 9.00 over the next 12 months.
This means that ANL's stock price may go up by +426.32% over the next 12 months.
We can't find any ETFs which contains Adlai Nortye Ltd. American Depositary Shares's stock.
As per our most recent records Adlai Nortye Ltd. American Depositary Shares has 127 Employees.
Adlai Nortye Ltd. American Depositary Shares's registered address is Ugland House, Grand Cayman, Cayman Islands, KY1-1104.
You can get more information about it from Adlai Nortye Ltd. American Depositary Shares's website at https://www.adlainortye.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Adlai Nortye Ltd. American Depositary Shares (ANL) Stock
Based on ratings from 1 analysts Adlai Nortye Ltd. American Depositary Shares's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on ANL's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for ANL is USD 9.00 over the next 12 months. The maximum analyst target price is USD 9 while the minimum anlayst target price is USD 9.
Unfortunately we do not have enough data on ANL's stock to indicate if its overvalued.
The last closing price of ANL's stock was USD 1.71.
The most recent market capitalization for ANL is USD 0.11B.
Based on targets from 1 analysts, the average taret price for ANL is projected at USD 9.00 over the next 12 months.
This means that ANL's stock price may go up by +426.32% over the next 12 months.
We can't find any ETFs which contains Adlai Nortye Ltd. American Depositary Shares's stock.
As per our most recent records Adlai Nortye Ltd. American Depositary Shares has 127 Employees.
Adlai Nortye Ltd. American Depositary Shares's registered address is Ugland House, Grand Cayman, Cayman Islands, KY1-1104.
You can get more information about it from Adlai Nortye Ltd. American Depositary Shares's website at https://www.adlainortye.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ANL !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
